Morning Note: COFB BB, NYR BB, ONTEX BB, SEQUA:BB
Cofinimmo: Non-core office building Bourg 105 soldNyrstar: Weak FY18 & 1Q19 results
Ontex: AGM provides more clarity on PAI discussion
Sequana Medical: First-In-Human heart DSR data achieve 1e endpoint
Cofinimmo is a fixed capital real estate investment trust. Co. specializes in rental property. Its core investment segments are office property and nursing and care institutions. The portfolio also includes a Distribution property networks segment. Most of Co.'s assets are in Belgium. The foreign part consists of nursing homes/ clinics and the MAAF agencies network in France and the Pubstone portfolio in the Netherlands. Co.'s operations are organized into four segments: Offices, Nursing homes/Clinics, Distribution property networks, and Public-Private Partnerships.
Nyrstar is a multi-metals company, produces and sells zinc and lead, as well as other metals, such as silver, gold, and copper. Co. produces zinc, which is used to protect steel from corrosion to construction and transport sectors. Co.'s products include zinc die casting alloys for hot chamber die casting processes, as well as niche alloys for special purposes to produce everyday objects, such as kitchen and bathroom fittings, toys, lock ware, zippers, and various auto and electronic components; zinc and special zinc alloys for the hot dip galvanizing industry; and zinc-continuous galvanizing products used in the construction, automotive, and consumer goods sectors.
Ontex Group NV is a Belgium-based company, which operates in the manufacturing sector of industry. The Company is a producer of disposable personal hygiene solutions for babies, women and adults. It offers a range of such products as baby diapers, baby pants, baby wet wipes, pads, pantyliners, tampons, light incontinence products, pull-ups, belt diapers, all-in-one tape systems, shaped pads and underpards. Its products are distributed through retail partner brands, as well as under its own brands (canbebe, canped, Helen Harper, Moltex, Baby Charm) across several distribution channels, such as retail trade, care institutions and pharmacies. The Company is present in Europe, Northern Africa, Australia and Asia.
Sequana Medical NV. Sequana Medical NV is a Belgium-based company, which manufactures medical devices. The Company focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
We are a financial services provider for several types of professional clients, each with distinct needs.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.